Latest filing published 11 Dec 2025 for Cannara Biotech Inc.. Read the official filing
No signal scores available.
Jack M. Kay is a declared insider of Cannara Biotech Inc., with filings sourced from SEDI. We count 2 filings; the first trade dates from 13 March 2023 and the latest from 8 December 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 11 December 2025 with an option exercise in Cannara Biotech Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations